Evidence map›Paper›PMID 34865173›Full record

SynthesisTransactions of the Royal Society of Tropical Medicine and Hygiene2022

Ebola virus disease in pregnancy: a systematic review and meta-analysis.

Nzelle D Kayem, Charlotte Benson, Christina Y L Aye, Sarah Barker, Mariana Tome, Stephen Kennedy, Proochista Ariana, Peter Horby

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Transactions of the Royal Society of Tropical Medicine and Hygiene, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nzelle D KayemNuffield Department of Medicine, University of Oxford, Oxford OX3 7LG, UK.ORCID 0000-0001-8308-3312
Charlotte BensonWomen's Centre, John Radcliffe Hospital, Oxford University Hospitals, Oxford OX3 9DU, UK.ORCID 0000-0002-3900-1049
Christina Y L AyeWomen's Centre, John Radcliffe Hospital, Oxford University Hospitals, Oxford OX3 9DU, UK.ORCID 0000-0002-6260-6740
Sarah BarkerWomen's Centre, John Radcliffe Hospital, Oxford University Hospitals, Oxford OX3 9DU, UK.ORCID 0000-0001-7682-7694
Mariana TomeNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.ORCID 0000-0002-1503-4161
Stephen KennedyNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.ORCID 0000-0003-0135-9317
Proochista ArianaNuffield Department of Medicine, University of Oxford, Oxford OX3 7LG, UK.ORCID 0000-0002-0154-2237
Peter HorbyNuffield Department of Medicine, University of Oxford, Oxford OX3 7LG, UK.ORCID 0000-0002-9822-1586

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review synthesises and appraises evidence on the effects of Ebola virus disease (EVD) in pregnancy. We searched bibliographic databases from dates of inception to November 2020, yielding 28 included studies. The absolute risk of maternal death associated with EVD was estimated at 67.8% (95% confidence interval [CI] 49.8 to 83.7, I2=85%, p<0.01) and the relative risk of death in pregnant women compared with non-pregnant women was estimated at 1.18 (95% CI 0.59 to 2.35, I2=31.0%, p=0.230). The absolute risk for foetal losses was estimated at 76.9% (95% CI 45.0 to 98.3, I2=96%, p<0.01) and neonatal death was 98.5% (95% CI 84.9 to 100, I2=0.0%, p=0.40). The gap analysis suggests limited or no data on the clinical course, non-fatal perinatal outcomes and EVD management in pregnant women. The review suggests that EVD has a high maternal and perinatal mortality, underscoring the urgent need for preventative and therapeutic solutions and improved screening and follow-up of pregnant women and newborns during outbreaks. There is not enough evidence to conclusively rule out pregnancy as a risk factor for mortality and there is limited evidence on the disease course, outcomes and management of EVD in pregnancy, and this supports the need for robust clinical trials and prospective studies that include pregnant women.

Indexed as

Hemorrhagic Fever, EbolaPregnancy Complications, InfectiousFemaleHumansInfant, NewbornPerinatal MortalityPregnancyProspective StudiesRisk Factorscase fatality rateEbolamaternal outcomesperinatal outcomes

Identifiers

PMID34865173
PMCPMC9157681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.